Nof-Ayalon, Israel

Haim Feldman

This inventor holds 47 USPTO granted patents and 8 published patent applications, primarily in Optical Inspection Systems. Top assignees: Applied Materials Israel Limited, Applied Materials, Inc., Applied Materials Isreal Ltd. Active years: 2000-2026.

USPTO Granted Patents = 47 

% Patents Active = 85.1

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 191(Granted Patents)


Location History:

  • Ayalon, IL (2010)
  • Nof-Aylon, IL (2011 - 2012)
  • Nof-Avalon, IL (2013 - 2014)
  • Nof-Ayalon, IL (2000 - 2023)

Company Filing History:


Years Active: 2000-2026

Loading Chart...
Areas of Expertise:
Light Source System
Defect Detection
Wafer Inspection
Optical Inspection
Multi-Spot Scanning
Pulsed Light Sources
High Throughput Inspection
Phase Contrast Microscopy
Simulation of Aerial Images
Dark Field Inspection
Laser Scanner
Asymmetrical Magnification
47 patents (USPTO):Explore Patents

Title: Haim Feldman: An Innovative Mind in Wafer Analysis

Introduction:

In the world of technological advancements and patents, Haim Feldman has emerged as a prominent inventor in the field of wafer analysis. With a plethora of patents under his belt and a significant contribution to the industry, Feldman has made a lasting impact with his innovative approaches. This article delves into his latest patents, career highlights, collaborative endeavors, and his overall contribution to the field.

Latest Patents:

One of Feldman's latest patented inventions is the "Multi-perspective Wafer Analysis." This method involves detecting defects on a sample by obtaining scan data from multiple perspectives. The integrated analysis of this data includes computing cross-perspective covariances and determining the presence of defects, taking into account these covariances. This invention showcases Feldman's dedication to improving the quality control measures in wafer analysis.

Another noteworthy patent is the "System and Method for Defect Detection Using Multi-spot Scanning." This invention comprises using a radiation source to generate coherent radiation, traveling lens optics to focus the beam into multiple spots on a sample's surface, and collecting scattered radiation to create a pattern of interference fringes. The detection unit, in turn, detects changes in the pattern of interference fringes. Such meticulous attention to detail demonstrates Feldman's commitment to enhancing defect detection techniques.

Career Highlights:

Throughout his journey, Haim Feldman has made significant contributions to renowned companies in the field. He has worked with Applied Materials Israel Limited, where he harnessed his expertise in wafer analysis and contributed to the company's innovative research and development. Additionally, his association with Applied Materials, Inc. further exemplifies his dedication to driving technological advancements in the field of wafer analysis.

Collaborations:

Feldman's accomplishments did not materialize in isolation, but rather through collaboration with talented individuals in the industry. Notable colleagues include Ron Naftali and Emanuel Elyasaf, who have shared their expertise and knowledge with Feldman, aiding in the realization of groundbreaking inventions. Their collaborative efforts have propelled the field of wafer analysis forward, pushing the boundaries of what is possible.

Conclusion:

Haim Feldman's journey as an inventor and his contribution to the field of wafer analysis have been truly remarkable. With numerous patents to his name, he has showcased his passion for innovation and commitment to improving defect detection methodologies. Feldman's work exemplifies the value of collaboration and his ability to leverage his expertise while working with prestigious companies further validates his credentials as a trailblazer. As Haim Feldman continues on his path of innovation, the field of wafer analysis can undoubtedly anticipate more groundbreaking inventions from this remarkable inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…